Stay updated on Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T13:43:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:36:46.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, with a simple header and a Home link. This indicates that access to the requested resource is blocked.
    Difference
    0.5%
    Check dated 2026-09-28T19:16:38.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the expected content, indicating an access-restricted state and preventing users from viewing the trial details and related information.
    Difference
    17%
    Check dated 2026-09-21T22:30:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page shows a new revision identifier, upgraded from v3.6.5 to v3.6.6, indicating an updated version of the page in the ClinicalTrials.gov record.
    Difference
    0.1%
    Check dated 2026-08-31T17:36:48.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new revision label, Revision: v3.6.5, has been added to replace the previous v3.6.4. This indicates an updated version reference in the page's records without changing substantive content.
    Difference
    0.1%
    Check dated 2026-08-10T11:57:39.000Z thumbnail image

Stay in the know with updates to Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.